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Background
The risk of developing latent TB infection (LTBI) fol-
lowing exposure to active tuberculosis (TB) in children
with rheumatic diseases on immunosuppressive therapy
is not well established.
Aim
To determine the risk of developing LTBI in children
with rheumatic diseases following inadvertent exposure
to active TB in the course of their clinical care.
Methods
Data from TB screening by tuberculin skin test (TST)
and interferon gamma release assay (Quantiferon TB
Gold In tube, (IGRA)) involving at-risk children with
rheumatic disease was reviewed. Exposed patients were
considered to be at moderate risk of LTBI if they were
under 5 years of age, or receiving conventional
DMARDs or corticosteroids > 0.5 mg/kg/day, and at
high risk if they were receiving biologic DMARDS. High
risk patients also had chest X-rays.
Results
Results from 55 children were analyzed; 13 (23.6%) in
the high risk category and 42 (76.4%) in the moderate
risk category. The duration of exposure to the index
case ranged from 30 to 120 minutes. Two children in
the high risk group on Etanercept tested positive for
TST (negative IGRA). All patients tested negative for
IGRA. A positive test result did not correlate with the
degree of immunosuppression or cumulative exposure.
No patients had symptoms or signs suggestive of active
TB and all chest radiographs were normal.
Conclusion
The risk of testing positive for LTBI was low in this
cohort of children, even in those on potent immunosup-
pressants. The sensitivity of TST and IGRA in this situa-
tion remains unknown.
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